Skip to main content
. 2022 May 10;43(9):5355–5362. doi: 10.1007/s10072-022-06111-x

Table 2.

PSG data from baseline to the 3-month follow-up visit

Baseline (mean ± SD) 3-month FU (mean ± SD) p-value
Lights off time (hh:mm:ss PM) 11:10:33 ± 1:10:23 11:14:18 ± 0:56:54 0.386
Time in bed (min) 408.93 ± 84.83 427.99 ± 62.86 0.814
Sleep latency (min) 24.43 ± 45.68 6.13 ± 7.22 0.034
Total sleep time (min) 316.92 ± 74.30 369.92 ± 65.03 0.136
Sleep efficiency (%) 78.56 ± 13.86 86.11 ± 7.03 0.084
REM sleep latency (min) 94.29 ± 46.11 116.96 ± 79.79 0.388
N1 (%) 6.41 ± 3.01 6.74 ± 6.59 0.505
N2 (%) 53.24 ± 10.30 50.10 ± 13.59 0.272
N3 (%) 25.79 ± 12.13 27.98 ± 12.99 0.308
REM (%) 14.53 ± 4.33 15.18 ± 7.20 1.000
WASO (min) 92.01 ± 67.41 58.38 ± 28.31 0.117

Abbreviations: FU, follow-up; WASO, wakefulness after sleep onset; N1, stage 1 of non-REM sleep; N2, stage 2 of non-REM sleep; N3, stage 3 of non-REM sleep; REM, rapid eye movement sleep; SD, standard deviation